Skip to content
HowShorted

Cabaletta Bio, Inc. short interest in 2021

In 2021, Cabaletta Bio, Inc.'s disclosed short interest ran from 6.10% of shares outstanding on 15 Jan 2021 to 6.43% on 31 Dec 2021, a change of +0.33 percentage points. The year's high was 7.25% on 31 Mar 2021 and its low 4.77% on 29 Oct 2021, averaging 6.14% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 29.93 days on 13 Aug 2021. Full history: Cabaletta Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Cabaletta Bio, Inc. in 2021

2021 in figures

Start of year
6.10% (15 Jan 2021)
End of year
6.43% (31 Dec 2021)
Change
+0.33 pp
High
7.25% (31 Mar 2021)
Low
4.77% (29 Oct 2021)
Average
6.14%
Highest days to cover
29.93 (13 Aug 2021)
SEC filings marked
8

Every report in 2021

Cabaletta Bio, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20216.10%12.52
29 Jan 20216.40%15.79
12 Feb 20216.69%21.80
26 Feb 20216.77%14.23
15 Mar 20217.13%14.71
31 Mar 20217.25%18.2610-K filed, results (8-K)
15 Apr 20217.04%20.14
30 Apr 20217.09%16.54
14 May 20216.75%13.5810-Q filed, results (8-K)
28 May 20216.35%24.96
15 Jun 20216.45%11.03
30 Jun 20215.67%4.49
15 Jul 20215.63%19.05
30 Jul 20215.32%27.80
13 Aug 20215.23%29.9310-Q filed, results (8-K)
31 Aug 20215.30%4.04
15 Sep 20215.36%7.15
30 Sep 20215.41%10.38
15 Oct 20215.42%10.28
29 Oct 20214.77%5.91
15 Nov 20215.81%8.0910-Q filed, results (8-K)
30 Nov 20216.43%12.06
15 Dec 20216.49%2.03
31 Dec 20216.43%1.00

See also: Cabaletta Bio, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.